BridgeBio Pharma (NASDAQ:BBIO) said on Monday that it intends to offer $500M aggregate principal amount of convertible senior ...
Now I would like to review the results of the 2026. Operating margin for the second fiscal quarter was 19.3%, above the high end of our guidance range of 17.3% to 18.5%. Operating margin increased 360 ...
MOU with Key Logistics Hub in North-Eastern Canada Supports and Advances Mont Royal's Development ...
Annaly Capital Management, Inc. ("Annaly" or the "Company") today announced its financial results for the quarter and year ended December 31, 2025. Financial Highlights GAAP net income of $1.40 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results